The Spectrum of Maculopathy in Mitochondrial DNA A3243G Mutation: A Case Series of Six Patients

Eirini Kaisari1, François-Xavier Borruat1

  • 1Ophthalmology, Jules Gonin Eye Hospital, Lausanne, Switzerland.

Klinische Monatsblatter Fur Augenheilkunde
|April 30, 2021
PubMed
Abstract

Insights

The mitochondrial DNA A3243G mutation can cause various disorders, including a specific retinopathy. This maculopathy presents as retinal pigment epithelium alterations and can impact vision, prompting further patient history for related conditions.

Area of Science:

  • Genetics
  • Ophthalmology
  • Neurology

Background:

  • The mitochondrial DNA (mtDNA) A3243G point mutation is associated with diverse clinical disorders such as MELAS, MIDD, and CPEO.
  • A distinct retinopathy pattern is consistently observed in individuals with the A3243G mtDNA mutation, irrespective of their primary clinical phenotype.

Purpose of the Study:

  • To describe the ocular manifestations, specifically retinopathy, associated with the A3243G mtDNA point mutation in a cohort of female patients.
  • To characterize the stages and visual impact of this specific retinopathy.

Main Methods:

  • Retrospective analysis of six female patients (ages 37-70) with the A3243G mtDNA mutation (diagnoses included MELAS, MIDD, and CPEO).
  • Ophthalmological examination including visual acuity, visual field testing, funduscopy, optical coherence tomography (OCT), and fundus autofluorescence.
  • Correlation of ocular findings with mutation type and clinical presentation.

Main Results:

  • All six patients presented with a maculopathy characterized by perimacular and peripapillary retinal pigment epithelium (RPE) alterations, including mottled dys-autofluorescence, RPE atrophy, and deposits on OCT.
  • Visual acuity ranged from 1/60 to 10/10, with visual field abnormalities varying from decreased sensitivity to central scotomas.
  • The degree of visual impairment correlated with foveal involvement and RPE atrophy extent; severity was not age-dependent. Long-term follow-up showed slow progression.

Conclusions:

  • The A3243G mtDNA point mutation can manifest with a spectrum of clinical phenotypes, including a characteristic maculopathy.
  • Ocular findings of RPE atrophy and deposits can significantly affect central vision, ranging from asymptomatic to legal blindness.
  • Ophthalmologists should consider the A3243G mutation in patients with this retinopathy and inquire about personal/family history of diabetes mellitus and deafness.